- Home
- RCUS vs RNST Comparison
RCUS vs RNST Comparison
Compare RCUS & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | RNST |
|---|---|---|
| Founded | 2015 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.0B |
| IPO Year | 2018 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RCUS | RNST |
|---|---|---|
| Price | $28.92 | $42.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $31.90 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 1.6M | 831.9K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.94 |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $31.72 |
| Revenue Next Year | $45.62 | $4.67 |
| P/E Ratio | ★ N/A | $44.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.84 | $33.04 |
| 52 Week High | $31.74 | $44.00 |
Technical Indicators
Market Signals| Indicator | RCUS | RNST |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 53.57 |
| Support Level | $22.79 | $39.10 |
| Resistance Level | $31.74 | $43.75 |
| Average True Range (ATR) | 1.72 | 0.92 |
| MACD | -0.01 | -0.16 |
| Stochastic Oscillator | 62.14 | 46.65 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.